PRECLINICAL DEVELOPMENT OF AN ANTIMALARIAL AGENT WITH A NEW MECHANISM OF ACTION

$3,099,575FY2018Defense Health AgencyDOD

The Broad Institute, Inc

Investigators

View source on USAspending →